Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(23 sites)
United States
Lumos Pharma Investigational Site, Birmingham, Alabama Lumos Pharma Investigational Site, Sacramento, California Lumos Pharma Investigational Site, Centennial, Colorado Lumos Pharma Investigational Site, Greenwood Village, Colorado Lumos Pharma Investigational Site, Washington D.C., District of Columbia Lumos Pharma Investigational Site, Miami, Florida Lumos Pharma Investigational Site, Orlando, Florida Lumos Pharma Investigational Site, Tallahassee, Florida Lumos Pharma Investigational Site, Indianapolis, Indiana Lumos Pharma Investigational Site, Iowa City, Iowa Lumos Pharma Investigational Site, New Orleans, Louisiana Lumos Pharma Investigational Site, Minneapolis, Minnesota Lumos Pharma Investigational Site, Kansas City, Missouri Lumos Pharma Investigational Site, Las Vegas, Nevada Lumos Pharma Investigational Site, New Brunswick, New Jersey Lumos Pharma Investigational Site, Staten Island, New York Lumos Pharma Investigational Site, Columbia, South Carolina Lumos Pharma Investigational Site, Corpus Christi, Texas Lumos Pharma Investigational Site, Charlottesville, Virginia Lumos Pharma Investigational Site, Seattle, Washington New Zealand
Lumos Pharma Investigational Site, Auckland Lumos Pharma Investigational Site, Wellington United Kingdom
Lumos Pharma Investigational Site, London, England